✦ LIBER ✦

Prevention trials in Alzheimer's disease: An EU-US task force report

✍ Scribed by Bruno Vellas; Paul S. Aisen; Cristina Sampaio; Maria Carrillo; Philip Scheltens; Bruno Scherrer; Giovanni B. Frisoni; Michael Weiner; Lon Schneider; Serge Gauthier; Christine C. Gispen-de Wied; Suzanne Hendrix; Howard Feldman; Jesse Cedarbaum; Ronald Petersen; Eric Siemers; Sandrine Andrieu; David Prvulovic; Jacques Touchon; Harald Hampel

Book ID: 116840223
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 249 KB
Volume: 95
Category: Article
ISSN: 0301-0082
DOI: 10.1016/j.pneurobio.2011.08.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alzheimer’s disease therapeutic trials:

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

✍ Vellas, B.; Hampel, H.; Rouge-Bugat, M. E.; Grundman, M.; Andrieu, S.; Abu-Shakr 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 91 KB

Disease-modifying trials in Alzheimer's

Disease-modifying trials in Alzheimer's disease: a European task force consensus

✍ Bruno Vellas; Sandrine Andrieu; Cristina Sampaio; Gordon Wilcock 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 94 KB

Endpoints for trials in Alzheimer's dise

Endpoints for trials in Alzheimer's disease: a European task force consensus

✍ Bruno Vellas; Sandrine Andrieu; Cristina Sampaio; Nicola Coley; Gordon Wilcock 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 133 KB

Task force on Alzheimer’s disease trial

Task force on Alzheimer’s disease trial methodology: Recruitment and retention, data management and analysis. The use of imaging in recruitment: Maintenance and methodological issues in Alzheimer’s trials

✍ Suhy, J. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 50 KB

Willingness to participate in an Alzheim

Willingness to participate in an Alzheimer's disease prevention trials among mild cognitively impaired elderly

✍ Evelyn D. Dominguez-R; Fadi Massoud; Mary C. Sano 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Caregiver time use: An outcome measure i

Caregiver time use: An outcome measure in clinical trial research on Alzheimer's disease*

✍ Clipp, Elizabeth C.; Moore, Michael J. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 969 KB

Object&e: To assess whether unpaid caregiver time and paid professional time increase as cognitive impairment associated with Alzheimer's disease increases and to evaluate the utility of caregiver time as an additional outcome measure in clinical trial research of Alzheimer's disease. Me&ek: This wa